Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel DiseaseMarieke J. H. Coenen, H. Akol, Sita H. Vermeulen et al.|Gastroenterology|2015Cited by 199
Risk Factors and Clinical Outcomes of Head and Neck Cancer in Inflammatory Bowel Disease: A Nationwide Cohort StudyLoes H.C. Nissen, Julie M. Janssen, Lauranne Derikx et al.|Inflammatory Bowel Diseases|2018Cited by 14